Over-expression of HO-1 on mesenchymal stem cells promotes angiogenesis and improves myocardial function in infarcted myocardium

Journal of Biomedical Science

Volumn 17, Issue 1, 2010, Pages

  Zeng, Bin ^a   Lin, Guosheng ^a   Ren, Xiaofeng ^b   Zhang, Yan ^a   Chen, Honglei ^c  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^c WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; FIBROBLAST GROWTH FACTOR 2; HEME OXYGENASE 1; PROTOPORPHYRIN ZINC; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENE OVEREXPRESSION; HEART FUNCTION; HEART INFARCTION; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CYTOLOGY; GENETICS; HEART MUSCLE; HEART VENTRICLE REMODELING; HEMODYNAMICS; MESENCHYMAL STEM CELL; METABOLISM; NICK END LABELING; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ANIMALS; APOPTOSIS; HEME OXYGENASE-1; HEMODYNAMICS; IN SITU NICK-END LABELING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR REMODELING;

EID: 77957348619     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-17-80     Document Type: Article

References (28)

1. Extracardiac approaches to protecting the heart. G Valen, Eur J Cardiothorac Surg 2009 35 651 657 10.1016/j.ejcts.2008.12.023 19216086
2. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. W Li N Ma LL Ong C Nesselmann C Klopsch Y Ladilov D Furlani C Piechaczek JM Moebius K Lützow A Lendlein C Stamm RK Li G Steinhoff, Stem Cells 2007 25 2118 2127 10.1634/stemcells.2006-0771 17478584
3. Connexin43 promotes survival of mesenchymal stem cells in ischaemic heart. D Wang W Shen F Zhang M Chen H Chen k Cao, Cell Biol Int 2010 12 415 423 10.1042/CBI20090118
4. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. M Gnecchi H He N Noiseux OD Liang L Zhang F Morello H Mu LG Melo RE Pratt JS Ingwall VJ Dzau, FASEB J 2006 20 661 669 10.1096/fj.05-5211com 16581974
5. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. R Tenhunen HS Marver R Schmid, Proc Natl Acad Sci USA 1968 61 748 755 10.1073/pnas.61.2.748 4386763
6. Effect of heme and heme oxygenase-1 on vascular endothelial growth factor synthesis and angiogenic potency of human keratinocytes. A Jazwa A Loboda S Golda J Cisowski M Szelag A Zagorska P Sroczynska J Drukala A Jozkowicz J Dulak, Free Radic Biol Med 2006 40 1250 63 10.1016/j.freeradbiomed.2005.11.016 16545694
7. Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. J Deshane S Chen S Caballero A Grochot-Przeczek H Was S Li Calzi R Lach TD Hock B Chen N Hill-Kapturczak GP Siegal J Dulak A Jozkowicz MB Grant A Agarwal, J Exp Med 2007 204 605 618 10.1084/jem.20061609 17339405
8. Significance of heme oxygenase in prolactin-mediated cell proliferation and angiogenesis in human endothelial cells. L Malaguarnera MR Pilastro S Quan MH Ghattas L Yang AV Mezentsev T Kushida NG Abraham A Kappas, Int J Mol Me 2002 10 433 440
9. Paracrine action of HO-1-modified mesenchymal stem cells mediates cardiac protection and functional improvement. B Zeng X Ren G Lin C Zhu H Chen J Yin H Jiang B Yang D Ding, Cell Biol Int 2008 32 1256 1264 10.1016/j.cellbi.2008.07. 010 18692581
10. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. SH Juan TS Lee KW Tseng W Durante, Circulation 2001 104 1519 1525 10.1161/hc3801.095663 11571246
11. Apoptosis in experimental myocardial infarction in situ and in the perfused heart in vitro. K Akiyama TL Gluckman A Terhakopian PM Jinadasa S Narayan S Singaswamy B Massey RJ Bing, Tissue Cell 1997 29 733 743 10.1016/S0040-8166(97)80049-3 9467933
12. Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. MC Fishbein D Maclean PR Maroko, Am J Pathol 1978 90 57 70 619696
13. Role of MAP kinases in nitric oxide induced muscle-derived adult stem cell apoptosis. D Bironaite D Baltriukiene N Uralova A Stulpinas V Bukelskiene A Imbrasaite A Kalvelyte, Cell Biol Int 2009 33 711 719 10.1016/j.cellbi.2009.03. 007 19376253
14. Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Müller-Ehmsen B Krausgrill V Burst K Schenk UC Neisen JW Fries BK Fleischmann J Hescheler RH Schwinger, J Mol Cell Cardiol 2006 41 876 884 10.1016/j.yjmcc.2006.07.023 16973174
15. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. YL Tang Y Tang YC Zhang K Qian L Shen MI Phillips, J Am Coll Cardiol 2005 46 1339 1350 10.1016/j.jacc.2005.05.079 16198853
16. Effect of heme and heme oxygenase-1 on vascular endothelial growth factor synthesis and angiogenic potency of human keratinocytes. A Jazwa A Loboda S Golda J Cisowski M Szelag A Zagorska P Sroczynska J Drukala A Jozkowicz J Dulak, Free Radic Biol Med 2006 40 1250 1263 10.1016/j.freeradbiomed.2005.11.016 16545694
17. Facilitated angiogenesis induced by heme oxygenase-1 gene transfer in a rat model of hindlimb ischemia. M Suzuki N Iso-o S Takeshita K Tsukamoto I Mori T Sato M Ohno R Nagai N Ishizaka, Biochem Biophys Res Commun 2003 302 138 143 10.1016/S0006-291X(03)00114-1 12593860
18. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. J Dulak A Jázkowicz A Dembinska-Kiec I Guevara A Zdzienicka D Zmudzinska-Grochot I Florek A Wájtowicz A Szuba JP Cooke, Arterioscler Thromb Vasc Biol 2000 20 659 666 10712388
19. Heme oxygenase and angiogenic activity of endothelial cells: stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX. A Jázkowicz I Huk A Nigisch G Weigel W Dietrich R Motterlini J Dulak, Antioxid Redox Signal 2003 5 155 162 10.1089/152308603764816514 12716475
20. Simultaneous surgical revascularization and angiogenic gene therapy in diffuse coronary artery disease. H Huwer C Welter C Ozbek M Seifert U Straub P Greilach G Kalweit H Isringhaus, Eur J Cardiothorac Surg 2001 20 1128 1134 10.1016/S1010-7940(01)01000-4 11717016
21. Additive effect of endothelial progenitor cell mobilization and bone marrow mononuclear cell transplantation on angiogenesis in mouse ischemic limbs. O Jeon SJ Song SH Bhang CY Choi MJ Kim BS Kim, J Biomed Sci 2007 14 323 330 10.1007/s11373-007-9145-7 17265168
22. Fibroblast growth factors: at the heart of angiogenesis. J Slavin, Cell Biol Int 1995 19 431 444 10.1006/cbir.1995.1087 7543787
23. Effect of FGF-1 and FGF-2 on VEGF binding to human umbilical vein endothelial cells. JH Chen XC Wang M Kan JD Sato, Cell Biol Int 2001 25 257 260 10.1006/cbir.2000.0617 11352499
24. Heme oxygenase-1 promotes neovascularization in ischemic heart by coinduction of VEGF and SDF-1. HH Lin YH Chen PF Chang YT Lee SF Yet LY Chau, J Mol Cell Cardiol 2008 45 44 55 10.1016/j.yjmcc.2008.04.011 18534615
25. A pressure overload model to track the molecular biology of heart failure. N Moorjani P Catarino R El-Sayed S Al-Ahmed B Meyer F Al-Mohanna S Westaby, Eur J Cardiothorac Surg 2003 24 920 925 10.1016/S1010-7940(03)00514-1 14643809
26. Role of calcineurin in Porphyromonas gingivalis-induced myocardial cell hypertrophy and apoptosis. SD Lee WW Kuo DY Lin TH Chen WH Kuo HH Hsu JZ Chen JY Liu YL Yeh CY Huang, J Biomed Sci 2006 13 251 260 10.1007/s11373-005-9048-4 16369686
27. Lipopolysaccharide preconditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction. Yongwei Yao Fumin Zhang Liansheng Wang Guohui Zhang Zhaojun Wang Jianmei Chen Xiang Gao, J Biomed Sci 2009 16 74 82 10.1186/1423-0127-16-74 19691857
28. Transmyocardial laser revascularization combined with vascular endothelial growth factor 121 (VEGF121) gene therapy for chronic myocardial ischemia - do the effects really add up? CA Heilmann T Attmann P von Samson H Göbel D Marmé F Beyersdorf G Lutter, Eur J Cardiothorac Surg 2003 23 74 80 10.1016/S1010-7940(02)00718-2 12493508